Search results
Vertex Is Writing A New Playbook For Pharma R&D. And It’s Working.
Forbes· 2 days ago...Sovaldi in December 2013 directly causing Incivek’s commercial flameout, Jeff Leiden, M.D.,...
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Ami
Guru Focus· 5 days agoThis announcement comes in the wake of a significant development where Vertex Pharmaceuticals Incorporated agreed to acquire Alpine for $65 per share in ...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 10 hours agoMeanwhile, the company's Casgevy treatment for sickle cell anemia, developed in partnership with ...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. | The Motley Fool
The Motley Fool· 10 hours agoCRISPR Therapeutics (CRSP 2.24%) closed last week down 8.5% after reporting first-quarter "earnings"...
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 3 days agoHere are two top stocks to consider buying now that you can hold for at least a decade. 1. Vertex ...
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
Zacks· 2 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
Investor's Business Daily· 1 day agoThe biotech company reported -7% earnings growth in its most recent report, while sales growth came...
Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
Investor's Business Daily· 7 days agoThe stock market rally had a quiet session for a second straight day. Nvidia fell slightly for a...
3 Cheap Biotech Stocks to Buy Now: May 2024
InvestorPlace· 1 day agoThe biotech industry is notably risky, but can produce stocks that see massive gains within a day. Well, many of these companies depend on FDA approval...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 9 hours agoNotably, Krystal is working on treatments for cystic fibrosis and alpha-a antitrypsin deficiency,...